ANALYSIS OF SNORNA EXPRESSION AND FUNCTION IN ACUTE MYELOID LEUKEMIA

EHA Library, Dennis Gerloff, 132427

PERSISTENCE AND EXPANSION OF HEMATOPOIETIC CLONES IN POST CHEMOTHERAPY AML ASSESED BY TARGET SEQUENCING

EHA Library, Daniela Soriano, 132428

IDENTIFICATION OF NOVEL PUTATIVE SNORNAS IN AML PATIENT SAMPLES

EHA Library, Dennis Gerloff, 132429

INHIBITION OF CXCR4 BY THE HIGH AFFINITY ANTAGONIST BL-8040 IN AML DOWNREGULATES BCL-2 THROUGH REGULATION OF MIR-15A/16-1 EXPRESSION

EHA Library, Michal Abraham, 132430

AML ORCHESTRATES MITOCHONDRIAL METABOLISM IN BONE MARROW MESENCHYMAL STROMAL CELLS THROUGH AN INCREASE OF PGC-1Α.

EHA Library, Christopher Marlein, 132431

PML-RARΑ REGULATES AKT THROUGH HSP90 INHIBITION IN APL BLASTS

EHA Library, Nélida Noguera, 132432

RUNX1-MUTATED AML SHOW A HIGH FREQUENCY OF TRISOMY 8 AND TRISOMY 13 AND ARE ASSOCIATED WITH MUTATIONS IN ASXL1 AND COMPONENTS OF THE RNA-SPLICING MACHINERY

EHA Library, Anna Stengel, 132433

REACTIVE OXYGEN SPECIES (ROS) MODULATES SENSITIVITY TO FLT3-TYROSINE KINASE INHIBITORS IN MURINE AND HUMAN FLT3-ITD POSITIVE AML CELL LINES.

EHA Library, Christian Mueller, 132434

COMBINING DOT1L INHIBITOR EPZ-5676 WITH SORAFENIB TO TREAT MLL-REARRANGED (MLL-R) PEDIATRIC ACUTE MYELOID LEUKEAMIA (AML)

EHA Library, Annalisa Lonetti, 132435

WHOLE EXOME SEQUENCING IDENTIFIES NOVEL MUTATIONS IN RELAPSED OR REFRACTORY ACUTE PROMYELOCYTIC LEUKAEMIA (APL) UNRESPONSIVE TO ORAL ARSENIC TRIOXIDE

EHA Library, Harinder Gill, 132436

MOLECULAR LANDSCAPE OF PRIMARY AND RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Annette Fasan, 132437

ACTIVATION OF NRF2 IN BONE MARROW MESENCHYMAL STROMAL CELLS MEDIATES SURVIVAL AND CHEMOTHERAPY RESISTANCE IN ACUTE MYELOID LEUKAEMIA BLASTS

EHA Library, Niamh Loughran, 132438

MICRORNAS HSA-LET-7A AND MIR-142-3P IN T CELLS IN PATIENTS PRESENTING WITH ACUTE MYELOID LEUKAEMIA – A MEANS OF REPAIRING TUMOUR-INDUCED T CELL DEFECTS?

EHA Library, Robert Petty, 132439

TP-1287, AN ORAL PRODRUG OF THE CYCLIN-DEPENDENT KINASE-9 INHIBITOR ALVOCIDIB

EHA Library, Clifford Whatcott, 132440

POST-INDUCTION MINIMAL RESIDUAL DISEASE ASSESSMENT BY BOTH MULTIPARAMETER FLOW CYTOMETRY AND RT-PCR PREDICTS OUTCOME IN ACUTE MYELOID LEUKEMIA

EHA Library, Claire Bories, 132441

PHARMACOLOGICAL INHIBITION OF THE PI3K/AKT/MTOR AND NF-KB CANCER PROMOTING PATHWAYS FOR TARGETED TREATMENT OF ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Andre Deslauriers, 132442

NPM1 MUTATION AND FLT3/ITD IN A DOUBLE TRANSGENIC ZEBRAFISH RECAPITULATES FEATURES OF HUMAN ACUTE MYELOID LEUKEMIA

EHA Library, Jeng-Wei Lu, 132443

THE MIR-128A/LIN28A AXIS REGULATES MYELOMONOCYTIC DIFFERENTIATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Luciana De Luca, 132444

DEEP SEQUENCING OF 23 GENES DESIGNATED BY TCGA STUDY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE

EHA Library, Mariam Ibañez, 132445

CD97 EXPRESSION MEDIATES MIGRATION AND ADHESION OF FLT3-ITD POSITIVE ACUTE MYELOID LEUKEMIA CELLS AND MODULATES THE BONE MARROW STROMAL MICROENVIRONMENT

EHA Library, Manja Wobus, 132446

REPOSITIONING OF QUINACRINE FOR TREATMENT OF ACUTE MYELOID LEUKEMIA - SYNERGIES AND IN VIVO EFFECTS

EHA Library, Anna Eriksson, 132447

PRIMARY ACUTE MYELOID LEUKEMIA CELLS WITH OVEREXPRESSION OF EVI-1 ARE SENSITIVE TO ALL TRANS RETINOIC ACID

EHA Library, Linda Smit, 132448

GENOME-WIDE ANALYSIS OF SINGLE NUCLEOTIDE POLYMORPHISM (SNPS) IN PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE

EHA Library, Mariam Ibañez, 132449

A NON-FUCOSYLATED FULLY HUMAN MONOCLONAL ANTIBODY AGAINST IL-3RΑ, KHK2823, SHOWS PROMISING PHARMACOLOGICAL CHARACTERISTICS IN NONCLINICAL STUDIES.

EHA Library, Tomonori Tawara, 132450

HETEROTYPIC SIGNALLING BETWEEN BONE MARROW STROMAL CELLS AND BLASTS PROVIDES INSIGHT INTO THE CELLULAR COMMUNICATION IN ACUTE MYELOID LEUKAEMIA

EHA Library, Arran Dokal, 132451

ONO-5390556 AS POTENTIAL TARGETED THERAPY FOR ACUTE MYELOID LEUKAEMIA WITH ETV6-NTRK3 FUSION GENE

EHA Library, Ryohei Kozaki, 132452

ASSESSMENT OF THE ALLELIC RATIO OF DNMT3A R882 MUTATIONS IN ACUTE MYELOID LEUKEMIA BY DIGITAL DROPLET PCR

EHA Library, Juliane Grimm, 132453

USE OF NGS MULTIGENIC PANEL IN MOLECULAR DIAGNOSTIC OF MYELOID MALIGNANCIES TO STRATIFY PATIENTS FOR PERSONALIZED THERAPIES

EHA Library, Eugenia Franchini, 132454

BIOLOGICAL MARKERS OF RELAPSE IN ELDERLY PATIENTS WITH AML IN CR AFTER INDUCTION-CONSOLIDATION CHEMOTHERAPY AND MAINTENANCE WITH 5-AZACITIDINE

EHA Library, Maria Cuzzola, 132455

PATTERNS OF INTERACTION BETWEEN MULTIPOTENT MESENCHYMAL STROMA CELLS (MSC) AND ACUTE MYELOID LEUKEMIA (AML) CELLS IN VITRO AND IN VIVO

EHA Library, Roland Schelker, 132456

THE ROLE OF THE NUCELOPHOSMIN-1 SPLICE VARIANT R2 IN ACUTE MYELOID LEUKEMIA DEVELOPMENT

EHA Library, Malgorzata Zajac, 132457

THE ROLE OF ADENOSINE DEAMINASE AND DNA METHYLATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Nilgun Tekin-Bubenheim, 132458

NEW DELETION OF JAK2 DETECTED BY SNP ARRAY IN ACUTE MYELOID LEUKEMIA: A ROLE IN OVERALL SURVIVAL

EHA Library, Viviana Guadagnuolo, 132459

PHASE 1B/2 STUDY OF VENETOCLAX WITH LOW-DOSE CYTARABINE IN TREATMENT-NAÏVE PATIENTS AGED ≥65 YEARS WITH ACUTE MYELOGENOUS LEUKEMIA

EHA Library, Andrew H Wei, 132460

CLINICAL OUTCOME AND EFFECT OF ALLO-SCT IN ADULT PATIENTS WITH DE NOVO OR AML-RELATED MYELOID SARCOMA. RESULTS FROM AN ITALIAN MULTICENTER SURVEY.

EHA Library, Davide Lazzarotto, 132461

OVEREXPRESSION OF ADAM28 ENHANCES ACUTE MYELOID LEUKEMIC CELL MIGRATION AND INCREASES THE GROWTH OF XENOGRAFT TUMOURS IN MICE

EHA Library, Yan Su, 132462

PROLONGED SURVIVAL IS ACHIEVABLE FOR A QUARTER OF PATIENTS IN PRIMARY INDUCTION FAILURE FOR ACUTE MYELOID LEUKEMIA, BUT DOES NOT RELY ON REPEATED SALVAGE THERAPY – A MONOCENTRIC RETROSPECTIVE STUDY

EHA Library, Marie-Pierre Ledoux, 132463

IMPACT OF SINGLE NUCLEOTIDE POLYMORPHISMS OF ABCB1 GENE UPON THE EFFECTIVENESS AND TOXICITY OF INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Juan Eduardo Megías-Vericat, 132464

CLEARANCE OF NPM1 MUTATION AT FIRST COMPLETE REMISSION AFTER INDUCTION THERAPY DID NOT PREDICT THE SURVIVAL IN FAVORABLE RISK GROUP WITH NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA

EHA Library, Seung-Shin Lee, 132465

VALIDATING THE PATIENT'S 'FITNESS' CRITERIA PROPOSED TO GUIDE TREATMENT DECISION IN ELDERLY AML : A MULTICENTER STUDY ON A SERIES OF 699 PATIENTS BY THE NETWORK 'RETE EMATOLOGICA LOMBARDA'

EHA Library, Chiara Pagani, 132466

CLINICAL CHARACTERISTICS AND OUTCOME OF PEDIATRIC ACUTE MYELOID LEUKEMIA WITH DEL(5Q) : A REPORT FROM THE JAPANESE PEDIATRIC LEUKEMIA/LYMPHOMA STUDY GROUP.

EHA Library, Akitoshi Kinoshita, 132467

DOSE ESCALATION STUDY OF CRENOLANIB IN COMBINATION WITH HIGH DOSE CYTARABINE/IDARUBICIN SALVAGE CHEMOTHERAPY IN MULTIPLY RELAPSED FLT3 POSITIVE AML

EHA Library, Jorge Cortes, 132468

QUANTIFICATION OF COMMON AND RARE NPM1 SUBTYPES USING A SINGLE MASSIVELY MULTIPLEX DIGITAL PCR ASSAY FOR MINIMAL RESIDUAL DISEASE IN AML

EHA Library, Nuria Mencia Trinchant, 132469

A SIMPLE 3-GENE MOLECULAR SCORE RETAINS HIGH PROGNOSTIC VALUE IN NON HIGH RISK ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH AIDA 2000 PROTOCOL: A RETROSPECTIVE STUDY FROM A REGIONAL REGISTER

EHA Library, Daniela Guardo, 132470

ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY PATIENTS (≥70 YRS): SEMI-INTENSIVE INDUCTION AND CONSOLIDATION WITH MAINTENANCE TREATMENT (1-YR) IN OUTPATIENT BASIS

EHA Library, Susana Vives Polo, 132471

COMBINATION OF RNA- AND EXOME-SEQUENCING EFFICIENTLY ELIMINATES FALSE-POSITIVE SOMATIC POINT MUTATIONS AND INDELS – EXEMPLIFIED BY CASES OF CN-AML

EHA Library, Marcus Hansen, 132472

A BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM-LIKE PHENOTYPE IDENTIFIES A SUBGROUP OF NPM1-MUTATED AML PATIENTS WITH WORSE PROGNOSIS

EHA Library, Paola Minetto, 132473

MFC -MRD ASSESSMENT MAY DRIVE POST INDUCTION CONSOLIDATION IN INTERMEDIATE RISK AML . IS IT TIME FOR MRD-DRIVEN DECISION MAKING?

EHA Library, Paola Minetto, 132474

ZYGODACTYLY IS STRONGLY ASSOCIATED WITH ACUTE MYELOID LEUKAEMIA

EHA Library, Aaron Niblock, 132476

CLINICAL DECISION SUPPORT SYSTEM (CDSS) BASED ON PATHWAYS-CONSTRAINED SOMATIC MUTATIONAL DATA INTEGRATION IN ACUTE MYELOID LEUKEMIA PERSONALIZED MEDICINE

EHA Library, Marco Manfrini, 132477

MOLECULAR RESPONSE IN ACUTE MYELOID LEUKEMIA WITH WT1 OVEREXPRESSION HAS A STRONG PROGNOSTIC IMPACT IN PATIENS TREATED WITH CHEMOTHERAPY ONLY AND/OR UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Cyril Salek, 132478

CHARACTERIZATION OF PATIENTS WITH RELAPSED OR REFRACTORY AML IN CONTINUED FOLLOW-UP AFTER TREATMENT WITH VOSAROXIN/CYTARABINE VS PLACEBO/CYTARABINE IN THE VALOR TRIAL

EHA Library, Arnaud Pigneux, 132479

DETECTION OF BASOPHIL-ASSOCIATED IMMUNOPHENOTYPIC FEATURES OF ACUTE PROMYELOCYTIC LEUKEMIA BLAST CELLS AT DIAGNOSIS IS ASSOCIATED TO A HIGHER AND MORE SEVERE BLEEDING DIATHESIS

EHA Library, Alberto Orfao, 132480

ASSESSMENT OF BAALC AND MN1 GENE EXPRESSION LEVEL COULD CONTRIBUTE TO IMPROVED PROGNOSTIC STRATIFICATION OF THE AML-NK PATIENTS

EHA Library, Irena Marjanovic, 132481

ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA AND NORMAL KARYOTYPE HAVE A FAVOURABLE OUTCOME AFTER INTENSIVE THERAPEUTIC PROGRAMS

EHA Library, massimo bernardi, 132482

THE HOMOZYGOUS TP53 P72R SNP IS ASSOCIATED WITH NON-FAVORABLE CYTOGENETIC RISK GROUPS IN ACUTE MYELOID LEUKEMIA

EHA Library, Eduard Schulz, 132483

FLAG-IDA REGIMEN AS SALVAGE THERAPY IN REFRACTORY/RELAPSED AML PATIENTS: A SINGLE-CENTER EXPERIENCE

EHA Library, Mario Delia, 132484

DECITABINE COMBINED WITH HAAG AS INDUCTION CHEMOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Xiaowen Tang, 132485

AGE FACTOR ON REMISSION INDUCTION THERAPY FOR ADULT ACUTE MYELOID LEUKEMIA

EHA Library, Hawk Kim, 132486

DEFINING FRAILTY OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA AT DIAGNOSIS

EHA Library, Ernesta Audisio, 132487

GENOTYPIC AND PHENOTYPIC CLONAL EVOLUTION IN RELAPSED FAVORABLE-ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Carmen Martinez Losada, 132488

DNMT3A MUTATIONS IN ACUTE MYELOID LEUKAEMIA WITH INTERMEDIATE-RISK KARYOTYPE - INCIDENCE AND CORRLEATION WITH OTHER GENE MUTATIONS

EHA Library, Gee Fung How, 132489

CLINICAL CHARACTERISTICS OF ACUTE MYELOID LEUKEMIA PATIENTS FROM REGIONS CONTAMINATED BY DEPLETED URANIUM: 20 YEAR ANALYSIS

EHA Library, Amina Kurtovic-Kozaric, 132490

COMPARISON OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION TO INTENSIVE CONSOLIDATION CHEMOTHERAPY AND MONITORING MINIMAL RESIDUAL DISEASE IN CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Hee Kyung Kim, 132491

PROGNOSTIC IMPLICATIONS OF THE IDH1 SINGLE NUCLEOTIDE POLYMORPHISM RS11554137 IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Irina Martynkevich, 132492

OUTCOMES WITH RITUXIMAB MONOTHERAPY VERSUS R-CHOP IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE ARISING AFTER SOLID ORGAN TRANSPLANT: A UNITED KINGDOM MULTICENTRE STUDY

EHA Library, David Burns, 132493

EXTRANODAL NK/T-CELL LYMPHOMA, NASAL TYPE OF ADVANCED STAGE: NKEA (NEXT-GENERATION THERAPY FOR NK/T-CELL LYMPHOMA IN EAST ASIA) PROJECT.

EHA Library, Ritsuro Suzuki, 132494

VALIDATION OF NCCN INTERNATIONAL PROGNOSTIC INDEX (NCCN-IPI) FOR DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL). THE ADDITION OF Β2MICROGLOBULIN RESULTED IN GELTAMO-IPI THAT IS MORE ACCURATE.

EHA Library, Carlos Montalban, 132495

EVALUATION OF A PROGNOSTIC MODEL FOR CNS RELAPSE WITHIN THE UK NCRI R-CHOP-14 VS 21 TRIAL

EHA Library, Gleeson Mary, 132496

SAFETY AND CLINICAL ACTIVITY OF TEMSIROLIMUS IN COMBINATION WITH RITUXIMAB AND DHAP IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA – PRELIMINARY RESULTS OF THE STORM TRIAL

EHA Library, Mathias Witzens-Harig, 132497

PROGNOSTIC FACTORS IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL) AFTER RITUXIMAB-CHOP (R-CHOP) WITH OR WITHOUT RADIOTHERAPY (RT): MATURE RESULTS OF A COOPERATIVE RETROSPECTIVE STUDY

EHA Library, Theodoros Vassilakopoulos, 132499

A POOLED DATA ANALYSIS OF TWELVE CLINICAL TRIALS OF FONDAZIONE ITALIANA LINFOMI (FIL): KHORANA SCORE AND HISTOTYPE PREDICT THE INCIDENCE OF EARLY VENOUS THROMBOEMBOLISM (VTE) IN NON HODGKIN LYMPHOMA

EHA Library, Roberto Santi, 132500

HEMOGLOBIN LEVEL IMPROVES THE ABILITY OF THE NATIONAL COMPREHENSIVE CANCER NETWORK INTERNATIONAL PROGNOSTIC INDEX TO PREDICT OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA - A POPULATION BASED COHORT STUDY.

EHA Library, Michael Clausen, 132501

ROUTINE IMAGING FOR PERIPHERAL T-CELL LYMPHOMA IN FIRST COMPLETE REMISSION DOES NOT IMPROVE SURVIVAL: A DANISH-SWEDISH POPULATION-BASED STUDY

EHA Library, Henrik Cederleuf, 132502

REAL-TIME CELL-OF-ORIGIN SUBTYPE IDENTIFICATION BY GENE EXPRESSION PROFILE IN THE PHASE 3 ROBUST TRIAL OF LENALIDOMIDE + R-CHOP VS PLACEBO + R-CHOP IN PREVIOUSLY UNTREATED ABC-TYPE DLBCL

EHA Library, Umberto Vitolo, 132503

MYD88 (L265P) MUTATION IS ASSOCIATED WITH AN UNFAVORABLE OUTCOME OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Keiichiro Hattori, 132504

SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB ADMINISTRATION IN FIRST-LINE DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA: PREFMAB STUDY OF PATIENT PREFERENCE AND SATISFACTION IN 19 COUNTRIES

EHA Library, Mathias Rummel, 132505

EXTRACORPOREAL PHOTOPHERESIS: SAFE AND EFFECTIVE FOR THE TREATMENT OF MYCOSIS FUNGOIDES

EHA Library, Erden Atilla, 132506

R-DA-EPOCH WITHOUT RADIOTHERAPY IN PRIMARY MEDIASTINAL LYMPHOMA PATIENTS RESULTS IN SIMILAR OUTCOME IN COMPARISON WITH A HISTORICAL COHORT TREATED WITH RADIOTHERAPY BASED REGIMENS.

EHA Library, Anna Guidetti, 132507

COMPARISON OF BONE MARROW ASPIRATE FLOW CYTOMETRY AND TREPHINE IMMUNOHISTOCHEMISTRY IN STAGING OF PATIENTS WITH LYMPHOMA.

EHA Library, Gulnaz Shah, 132508

EVALUATION OF THE NEW PROGNOSTIC SCORE IN HIV RELATED NON HODGKIN LYMPHOMA. EXPERIENCE IN UNIVERSITY HOSPITAL SON ESPASES.

EHA Library, Silvia Ruiz De Gracia, 132509

SERUM IL-10 LEVEL PREDICTS POOR PROGNOSIS IN PATIENTS WITH ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: RESULTS OF A SINGLE CENTER COHORT STUDY

EHA Library, Seok Jin Kim, 132510

REDUCED RCHOP FOR ELDERLY PATIENTS WITH DLBCL

EHA Library, Liat Vidal, 132511

A PREDICTIVE SCORE FOR CNS DISSEMINATION AND ITS EFFECT ON CNS PROPHYLAXIS IN A MONO-INSTITUTIONAL SERIES OF 242 PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED IN THE RITUXIMAB ERA

EHA Library, Andres Jose Maria Ferreri, 132512

A PHASE I STUDY IN T CELL LYMPHOMA PATIENTS TREATED WITH ANTI-CD70 SIMPLE ANTIBODY™ ARGX-110

EHA Library, Jean-Marie Michot, 132513

DOUBLE PROTEIN LYMPHOMA PATIENTS OF THE NON-GCB SUBTYPE HAVE AN INFERIOR PROGNOSIS WHEN TREATED WITH CHEMOIMMUNOTHERAPY

EHA Library, Katharina Troppan, 132514

A CLINICO-PATHOLOGIC AND IMMUNOHISTOCHEMICAL ANALYSIS OF ORAL AND EXTRA-ORAL PLASMABLASTIC LYMPHOMA IN SOUTH AFRICA

EHA Library, Shabnum Meer, 132515

A NGS IGK ASSAY FOR THE DETECTION OF CLONALITY AND THE MONITORING OF MINIMAL RESIDUAL DISEASE

EHA Library, Zhiyi Xie, 132516

DE NOVO TRANSFORMED FOLICULAR LYMPHOMA. OUTCOMES AND ROLE OF AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Miguel Alcoceba, 132517

LOW EXPRESSION OF MIR-155 IN VINCRISTINE RESISTANT DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Hanne Due Rasmussen, 132518

RITUXIMAB AND HIGH DOSE CYTARABINE WITH AUTOLOGOUS TRANSPLANTATION FOR MANTLE CELL LYMPHOMA

EHA Library, Samuel Howard Burrows, 132519

TREATMENT OF INITIAL CENTRAL NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC AGGRESSIVE LYMPHOMA WITH HIGH DOSE METHOTREXATE AND R-CHOP

EHA Library, Marcel Nijland, 132520

FEASIBILITY AND EFFICACY OF DHAOX REGIMEN AS SALVAGE AND MOBILIZING THERAPY IN RELAPSED /REFRACTORY LYMPHOMAS.

EHA Library, Elisa Coviello, 132521

OUTCOMES OF 34 PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA IN RITUXIMAB ERA AT A SINGLE INSTITUTION

EHA Library, Noriko Nishimura, 132523

PATIENTS WITH PRIMARY CNS LYMPHOMA OR PRIMARY TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA HAVE AN INFERIOR PROGNOSIS WHEN CO-EXPRESSING C-MYC AND BCL2.

EHA Library, Katharina Troppan, 132524

CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA. A SINGLE CENTER ANALYSIS OF THE RISK FACTORS AND THE IMPACT OF CNS PROPHYLAXIS IN THE RITUXIMAB ERA

EHA Library, Michela Ansuinelli, 132525

SURVIVAL IMPACT OF SERUM ALBUMIN (SA) IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) RELATED NON-HODGKIN’S LYMPHOMAS

EHA Library, Joseph Clara, 132526

OUTCOME FOR PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA TREATED WITH GEMCITABINE AND OXALIPLATIN WITH OR WITHOUT RITUXIMAB

EHA Library, Vijayavalli Dhanapal, 132527

DOSE-ADJUSTED ETOPOSIDE-PREDNISONE-VINCRISTINE-CYCLOPHOSPHAMIDE-DOXORUBICIN-RITUXIMAB (DA-EPOCH-R) FOR PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL) AND OTHER VERY HIGH-RISK OR ADVANCED LYMPHOMAS

EHA Library, Francesca Carobolante, 132528

ELDERLY AGE IS NOT EXCLUSION FACTOR FOR INTENSIVE THERAPY BY SCHEME R-DA-EPOCH/R-HMA FOR PATIENTS WITH UNTREATED HIGH-GRADE DIFFUSE LARGE B-CELL LYMPHOMA.

EHA Library, Olga Aleshina (Gavrilina), 132529